Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Oh

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Theriogenology|December 16, 2006
Birth of viable female dogs produced by somatic cell nuclear transferG Jang, M K Kim, H J Oh, et al.
Journal of Medicinal Chemistry|November 7, 1998
Use of papain as a model for the structure-based design of cathepsin K inhibitors: crystal structures of two papain-inhibitor complexes demonstrate binding to S'-subsitesJ M LaLonde, B Zhao, W W Smith, et al.
The Journal of Biological Chemistry|January 20, 2001
Potent and selective cathepsin L inhibitors do not inhibit human osteoclast resorption in vitroI E James, R W Marquis, S M Blake, et al.
Journal of Medicinal Chemistry|September 1, 1980
6-(Phenylthio)-substituted 2,3,4,5-tetrahydro-1H-3-benzazepines, a novel class of dopamine receptor antagonists and neurolepticsC Kaiser, F E Ali, W E Bondinell, et al.
Journal of Medicinal Chemistry|September 11, 1998
Conformationally constrained 1,3-diamino ketones: a series of potent inhibitors of the cysteine protease cathepsin KR W Marquis, D S Yamashita, Y Ru, et al.
Bioorganic & Medicinal Chemistry|June 3, 1999
Potent dipeptidylketone inhibitors of the cysteine protease cathepsin KR W Marquis, Y Ru, D S Yamashita, et al.
Journal of Medicinal Chemistry|April 20, 2001
Azepanone-based inhibitors of human and rat cathepsin KR W Marquis, Y Ru, S M LoCastro, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Theriogenology|December 16, 2006
Birth of viable female dogs produced by somatic cell nuclear transferG Jang, M K Kim, H J Oh, et al.
Journal of Medicinal Chemistry|November 7, 1998
Use of papain as a model for the structure-based design of cathepsin K inhibitors: crystal structures of two papain-inhibitor complexes demonstrate binding to S'-subsitesJ M LaLonde, B Zhao, W W Smith, et al.
The Journal of Biological Chemistry|January 20, 2001
Potent and selective cathepsin L inhibitors do not inhibit human osteoclast resorption in vitroI E James, R W Marquis, S M Blake, et al.
Journal of Medicinal Chemistry|September 1, 1980
6-(Phenylthio)-substituted 2,3,4,5-tetrahydro-1H-3-benzazepines, a novel class of dopamine receptor antagonists and neurolepticsC Kaiser, F E Ali, W E Bondinell, et al.
Journal of Medicinal Chemistry|September 11, 1998
Conformationally constrained 1,3-diamino ketones: a series of potent inhibitors of the cysteine protease cathepsin KR W Marquis, D S Yamashita, Y Ru, et al.
Bioorganic & Medicinal Chemistry|June 3, 1999
Potent dipeptidylketone inhibitors of the cysteine protease cathepsin KR W Marquis, Y Ru, D S Yamashita, et al.
Journal of Medicinal Chemistry|April 20, 2001
Azepanone-based inhibitors of human and rat cathepsin KR W Marquis, Y Ru, S M LoCastro, et al.
Pageof 7